Alpha-CGRP (19-37) (Human) is a peptide derived from the calcitonin gene-related peptide (CGRP) family, which plays a significant role in various physiological processes, including vasodilation and pain transmission. This specific fragment, consisting of 19 to 37 amino acids of the human CGRP sequence, is known for its neuropeptide activity and is involved in the modulation of inflammatory responses and nociceptive pathways. The peptide is characterized by its ability to bind to CGRP receptors, influencing cardiovascular functions and potentially serving as a target for therapeutic interventions in conditions like migraine and other pain disorders. Alpha-CGRP (19-37) is typically synthesized for research purposes and may exhibit stability under physiological conditions, although its activity can be influenced by factors such as pH and temperature. As a synthetic peptide, it is often utilized in studies exploring the mechanisms of CGRP-related signaling pathways and the development of CGRP antagonists for clinical applications.

ALPHA-CGRP (19-37) (HUMAN)

101233-12-9: Alpha-CGRP (19-37) (Human) is a peptide derived from the calcitonin gene-related peptide (CGRP) family, which plays a significant role in various physiological processes, including vasodilation and pain transmission. This specific fragment, consisting of 19 to 37 amino acids of the human CGRP sequence, is known for its neuropeptide activity and is involved in the modulation of inflammatory responses and nociceptive pathways. The peptide is characterized by its ability to bind to CGRP receptors, influencing cardiovascular functions and potentially serving as a target for therapeutic interventions in conditions like migraine and other pain disorders. Alpha-CGRP (19-37) is typically synthesized for research purposes and may exhibit stability under physiological conditions, although its activity can be influenced by factors such as pH and temperature. As a synthetic peptide, it is often utilized in studies exploring the mechanisms of CGRP-related signaling pathways and the development of CGRP antagonists for clinical applications.

<p>Please enquire for more information about Alpha-CGRP (19-37) (human) including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

CAS 101233-12-9

ALPHA-CGRP (19-37) (HUMAN)

α-CGRP (19-37) (human)

Ref: 3D-FC110362